Allergan Continues Legal Sparring With Cosmetic Eyelash-Growth Brands
This article was originally published in The Rose Sheet
Executive Summary
Latisse marketer Allergan continues to lock horns with cosmetic firms offering non-FDA-approved, prostaglandin-based eyelash-enhancement products, pursuing injunction and damages in California court.